These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32865162)

  • 1. Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.
    Smith AT; Kennerly-Shah JM; Kusoski CL
    J Oncol Pharm Pract; 2020 Oct; 26(7):1686-1694. PubMed ID: 32865162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center.
    Valgus JM; Faso A; Gregory KM; Jarr S; Savage S; Caiola S; Walko CM; Kim J; Bernard SA
    Am J Health Syst Pharm; 2011 Apr; 68(7):613-9. PubMed ID: 21411803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring practice site contributions and professionalization impact of engaging student pharmacists on hematology-oncology advanced pharmacy practice experience rotations.
    Yacobucci MJ; Lombardi CL; Briceland LL
    J Oncol Pharm Pract; 2022 Jan; 28(1):109-118. PubMed ID: 33470177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an operational productivity tool within a cancer treatment center pharmacy.
    Achey TS; Riffle AR; Rose RM; Earl M
    Am J Health Syst Pharm; 2018 Nov; 75(21):1736-1741. PubMed ID: 30282665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Method to determine allocation of clinical pharmacist resources.
    Granko RP; Poppe LB; Savage SW; Daniels R; Smith EA; Leese P
    Am J Health Syst Pharm; 2012 Aug; 69(16):1398-404. PubMed ID: 22855106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of clinical pharmacy in oncology and hematology centers: A systematic review.
    Oliveira CS; Silva MP; Miranda ÍKSPB; Calumby RT; de Araújo-Calumby RF
    J Oncol Pharm Pract; 2021 Apr; 27(3):679-692. PubMed ID: 33302824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of clinical pharmacy services in a hematology/oncology inpatient setting.
    Delpeuch A; Leveque D; Gourieux B; Herbrecht R
    Anticancer Res; 2015 Jan; 35(1):457-60. PubMed ID: 25550587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
    Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
    J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions.
    Wyatt H; Zuckerman AD; Hughes ME; Arnall J; Miller R
    J Oncol Pharm Pract; 2022 Apr; 28(3):627-634. PubMed ID: 35037778
    [No Abstract]   [Full Text] [Related]  

  • 10. Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting.
    McBride A; Campen CJ; Camamo J; Maloney M; Persky D; Kurtin SE; Barket NL; Krishnadasan R; Elquza E; Anwer F; Weibel K
    Am J Health Syst Pharm; 2018 May; 75(9):e246-e258. PubMed ID: 29691269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey.
    Griffin SP; Signorelli JR; Lasko A; Andrick BJ; Doan D; Hough S; Riebandt G; Harnicar S
    J Oncol Pharm Pract; 2024 Mar; 30(2):332-341. PubMed ID: 37194276
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining, capturing, and validating pharmacists' patient profile reviews in the electronic medical record.
    Smith A; Begnoche B; Mellett J; Hafford A; Rodis JL; Jordan TA
    Am J Health Syst Pharm; 2022 Nov; 79(23):2166-2173. PubMed ID: 36056788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intersecting care through specialized pharmacists: A case report of residency rotation focused on the new horizon of cardio-oncology.
    Einsfeld L; do Canto Olegário I; Fagundes ML
    Curr Pharm Teach Learn; 2023 May; 15(5):508-513. PubMed ID: 37183144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' roles in oncology pharmacy services: Results of a global survey.
    Holle LM; Harris CS; Chan A; Fahrenbruch RJ; Labdi BA; Mohs JE; Norris LB; Perkins J; Vela CM
    J Oncol Pharm Pract; 2017 Apr; 23(3):185-194. PubMed ID: 26854267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scoring big: Aligning inpatient clinical pharmacy services through implementation of an electronic scoring system.
    Patel N; To L; Griebe K; Efta J; Knoth N; Johnson J; Fitzmaurice MG; Bajwa M; Stuart M; Procopio V; Stine J; MacDonald NC; Peters M; Ratusznik M; Kalus J
    Am J Health Syst Pharm; 2024 Mar; 81(6):226-234. PubMed ID: 38070494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of clinical pharmacy services in a hematology/oncology ward in Morocco.
    Moukafih B; Abahssain H; Mrabti H; Errihani H; Rahali Y; Taoufik J; Chaibi A
    J Oncol Pharm Pract; 2021 Mar; 27(2):305-311. PubMed ID: 32326873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of clinical pharmacists into an ambulatory, pediatric hematology/oncology/transplant clinic.
    Defoe KD; Jupp J; Leslie T
    J Oncol Pharm Pract; 2019 Apr; 25(3):607-612. PubMed ID: 29451420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding care through a layered learning practice model.
    Bates JS; Buie LW; Amerine LB; Savage SW; Eckel SF; Patel R; Valgus JM; Rao K; Daniels R
    Am J Health Syst Pharm; 2016 Nov; 73(22):1869-1875. PubMed ID: 27663562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Economic Impact of Pharmacists' Intervention on Care of Pediatric Hematology and Oncology Patients.
    Kim HJ; Lee S; Lee YJ; Kim S; Jo YH; Cho YS; An HY; Hong KT; Choi JY; Kang HJ; Shin HY; Lee JY
    J Oncol Pharm Pract; 2023 Mar; 29(2):319-325. PubMed ID: 34931912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
    Przybylski DJ; Dow-Hillgartner EN; Reed MP; Fallon MJ
    J Oncol Pharm Pract; 2020 Sep; 26(6):1374-1381. PubMed ID: 31937189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.